Skip to main content
. 2014 Apr 29;38(3):173–179. doi: 10.1016/j.jgr.2014.04.003

Fig. 5.

Fig. 5

Morphological assessment of human rhinovirus 3 (HRV3)-infected Hela cells following ginsenosides treatment. HRV3-infected and uninfected HeLa cells were treated with either ribavirin or 100 μg/mL ginsenoside. After staining of viable cells with sulforhodamine B (SRB), cell morphology was assessed by microscopy. (A) Untreated, uninfected cells; (B–I) uninfected cells treated with ginsenosides (B) Rb1, (C) Rb2, (D) Rd, (E) Rc, (F) Re, (G) Rf, (H) Rg2; and with (I) ribavirin; (J) untreated HRV3-infected cells; (K—R) HRV3-infected cells treated with ginsenosides (K) Rb1, (L) Rb2, (M) Rd, (N) Rc, (O) Re, (P) Rf, (Q) Rg2; and with (R) ribavirin.